FAKTOR-OPTIONSSCHEIN - SMITH & NEPHEW | Real-time Bid/Ask 06:30:08 2024-07-11 am EDT | ||
| 2.14 EUR / 2.16 EUR | +2.38% |
|
| Current month | -74.85% | ||
| 1 month | -61.33% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
SMITH & NEPHEW PLC
Latest news about SMITH & NEPHEW PLC
More news
| Date | Price | Change |
|---|---|---|
| 24-07-11 | 2.03 | -3.33% |
| 24-07-10 | 2.1 | -10.64% |
| 24-07-09 | 2.35 | -13.28% |
| 24-07-08 | 2.71 | -5.24% |
| 24-07-05 | 2.86 | +10.00% |
Delayed Quote Börse Stuttgart
Last update July 11, 2024 at 04:50 am EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | SMITH & NEPHEW PLC |
| Issuer | Morgan Stanley |
| WKN | MG2XME |
| ISIN | DE000MG2XME2 |
| Date issued | 2024-04-24 |
| Strike | 1,201 p |
| Maturity | Unlimited |
| Parity | 0.64 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.6 € |
|---|---|
| Lowest since issue | 2.01 € |
| Spread | 0.02 € |
| Spread % | 0.94% |
Company Profile
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipment. Net sales break down by activity sector as follows:
- orthopedic surgery (39.9%): primarily orthopedic implants (hips, knees and shoulders);
- sports medicine, arthroscopy and cervicofacial surgery (31.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.;
- wound care (28.9%): skin grafts for major burns victims, treatments for leg ulcers, etc.
The United States accounts for 53.7% of net sales.
Sector
-
Consensus: Smith & Nephew Plc
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
14.03
USD
Average target price
16.41
USD
Spread / Average Target
+16.97%
- Stock Market
- Certificates
- Certificat
